TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announced its financial results for the...
TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.PR.D) (“Dundee”) announced today that its board of directors has approved the...
TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.PR.B) (“Dundee”) announced today that its board of directors has approved the...
TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A, DC.PR.B, DC.PR.D) (“Dundee” or the “Company”) announces the cancellation of its...
TORONTO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A, DC.PR.B, DC.PR.D) (“Dundee” or the “Company”) announced today that its second...
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (“Dundee” or the “Company”) is pleased to announce the voting results from its...
TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announces that TauRx Pharmaceuticals Ltd....
TORONTO, May 11, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.PR.D) (“Dundee”) announced today that its board of directors has approved the...
TORONTO, May 11, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.PR.B) (“Dundee”) announced today that its board of directors has approved the...
TORONTO, May 11, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announced its financial results for the...